Eosinophil may be a predictor of immune‐related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study

Eosinophil may be a predictor of immune‐related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study

Abstract Background Immune checkpoint inhibitors (ICIs) can cause severe immune‐related adverse events (irAEs). However, biomarkers for irAEs common to different types of ICIs and cancers have not been reported. This study examined whether eosinophils can be used as a predictor of irAEs. Methods Six...

Full description

Bibliographic Details
Main Authors: Yoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto, Taku Naiki, Takehiro Uemura, Keisuke Yokota, Daisuke Kawakita, Motoki Nakamura, Ryo Ogawa, Takaya Shimura, Yoshihisa Mimura, Yuji Hotta, Kunihiro Odagiri, Nanami Ito, Moeko Iida, Yuka Kimura, Hirokazu Komatsu, Hiromi Kataoka, Shuji Takiguchi, Akimichi Morita, Shinichi Iwasaki, Katsuhiro Okuda, Akio Niimi, Takahiro Yasui, Yoko Furukawa‐Hibi
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Cancer Medicine
Subjects:
biomarker
cancer
eosinophil
immune checkpoint inhibitor
immune‐related adverse event
Online Access:https://doi.org/10.1002/cam4.6724

Internet

https://doi.org/10.1002/cam4.6724

Similar Items